Literature DB >> 31188208

Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA): Zone I Balloon Occlusion Time Affects Spinal Cord Injury in the Nonhuman Primate Model.

Jonathan L Eliason1, Daniel D Myers1, Abhijit Ghosh1, Jonathan J Morrison2, Angela R Mathues1, Laura Durham1, Veronica Dunivant1, Andrew A Gonzalez1, Todd E Rasmussen3.   

Abstract

OBJECTIVES: Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) has been used clinically to limit torso bleeding and restore central perfusion. The objective of this study was to determine the sequelae of prolonged REBOA in a nonhuman primate animal model. SUMMARY BACKGROUND DATA: Prolonged duration of REBOA is associated with adverse clinical outcomes. Threshold occlusion values tied to relative risk have yet to be determined.
METHODS: Juvenile baboons were subjected to 40% to 55% total blood volume hemorrhage to achieve profound hypotension and shock. Zone I REBOA was performed for 60 minutes to assess acute injury and survival at 4 hours (group 1; n = 7). Post-REBOA 10-day survival and complications were then compared between 60 minutes (group 2; n = 8) and 30 minutes (group 3; n = 6) REBOA animals.
RESULTS: Overall survival was 20/21 (95%). IL-6 and IL-8 were elevated at 1 and 4 hours in group 1 (P = 0.005; P = 0.001). Comparing 60-minute REBOA with 30-minute REBOA, there was (1) hypertension compared with normotension (P = 0.005), (2) increased base deficit (P = 0.003), (3) elevated Troponin I (P = 0.04), and histological evidence of kidney injury (P = 0.004). In addition, group 2 demonstrated paralysis with histopathologic changes of spinal cord ischemia (SCI) in 4/8 (50%), with no SCI in group 3 (P = 0.033).
CONCLUSIONS: REBOA limits mortality in the primate model of severe hemorrhagic shock. However, unopposed balloon inflation in the distal thoracic aorta for 60 minutes results in high rates of spinal cord ischemia, an effect mitigated by limiting balloon inflation to 30 minutes.
Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 31188208     DOI: 10.1097/SLA.0000000000003408

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  6 in total

Review 1.  Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA): update and insights into current practices and future directions for research and implementation.

Authors:  Marianne A Thrailkill; Kevin H Gladin; Catherine R Thorpe; Teryn R Roberts; Jae H Choi; Kevin K Chung; Corina N Necsoiu; Todd E Rasmussen; Leopoldo C Cancio; Andriy I Batchinsky
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2021-01-06       Impact factor: 2.953

Review 2.  Damage control approach to refractory neurogenic shock: a new proposal to a well-established algorithm.

Authors:  Michael W Parra; Carlos A Ordoñez; David Mejia; Yaset Caicedo; Javier Mauricio Lobato; Oscar Javier Castro; Jose Alfonso Uribe; Fernando Velásquez
Journal:  Colomb Med (Cali)       Date:  2021-06-30

3.  A clinical study of the hemodynamic and metabolic effects of Zone 3 REBOA for sacral and pelvic tumor resections.

Authors:  Zhiqing Zhao; Jichuan Wang; Taiqiang Yan; Wei Guo; Rongli Yang; Xiaodong Tang; Yi Yang
Journal:  BMC Surg       Date:  2022-06-27       Impact factor: 2.030

4.  Automated Partial Versus Complete Resuscitative Endovascular Balloon Occlusion of the Aorta for the Management of Hemorrhagic Shock in a Pig Model of Polytrauma: a Randomized Controlled Pilot Study.

Authors:  Guillaume L Hoareau; Carl A Beyer; Connor A Caples; Marguerite W Spruce; J Kevin Grayson; Lucas P Neff; Timothy K Williams; M Austin Johnson
Journal:  Mil Med       Date:  2020-12-30       Impact factor: 1.437

5.  Distal organ inflammation and injury after resuscitative endovascular balloon occlusion of the aorta in a porcine model of severe hemorrhagic shock.

Authors:  Yansong Li; Michael A Dubick; Zhangsheng Yang; Johnny L Barr; Brandon J Gremmer; Michael L Lucas; Corina Necsoiu; Bryan S Jordan; Andriy I Batchinsky; Leopoldo C Cancio
Journal:  PLoS One       Date:  2020-11-17       Impact factor: 3.240

6.  Determination of optimal deployment strategy for REBOA in patients with non-compressible hemorrhage below the diaphragm.

Authors:  Nicholas L Johnson; Charles E Wade; Erin E Fox; David E Meyer; Charles J Fox; Ernest E Moore; Jonathan Morrison; Thomas Scalea; Eileen M Bulger; Kenji Inaba; Bryan C Morse; Laura J Moore
Journal:  Trauma Surg Acute Care Open       Date:  2021-02-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.